Two Sigma Securities’s Biostage, Inc. Common Stock BSTG Stock Holding History

Two Sigma Securities’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25,915	Closed	-$8K	–	2166
2017 Q3	$8K	Buy	25,915 +8,541	+49%	+$3.42K	﹤0.01%	877
2017 Q2	$7K	Buy	+17,374	New	+$5.52K	﹤0.01%	821
2017 Q1	–	Sell	-22,997	Closed	-$20K	–	1230
2016 Q4	$20K	Buy	+22,997	New	+$20.5K	0.01%	654

Two Sigma Securities's BSTG Position: Q4 2017 in Review

Two Sigma Securities sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 25,915 shares — an estimated $8K sold.

Two Sigma Securities first reported a position in BSTG in Q4 2016 and held it in 3 quarters. The position peaked at $20K in Q4 2016. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

Two Sigma Securities reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Two Sigma Securities sold 25,915 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $8K.
Two Sigma Securities first reported a position in Biostage, Inc. Common Stock in Q4 2016 and held it in 3 quarters.
Two Sigma Securities's Biostage, Inc. Common Stock position peaked at $20K in Q4 2016.
0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Two Sigma Securities's 13F filing for Q4 2017, filed 14 Feb 2018.